The Market Access Lead Obesity will shape the global development and access strategy for a first-in-class obesity triple agonist, leading end-to-end accountability for Market Access, including pricing and value strategy, payer-informed clinical development support, evidence generation, and global launch and reimbursement strategy.
Requirements
- Senior market access leader with deep expertise in Obesity/GLP-1 global access and commercialization, operating at asset, franchise, or portfolio leadership level
- Extensive experience developing and executing global, regional, and local market access strategies, integrating payer insights and aligning with therapeutic area priorities
- Strong expertise in value-based pricing, evidence generation, and payer-focused value propositions aligned with healthcare system needs
- Demonstrated success in developing channel-specific access strategies, including cash / out-of-pocket models and engagement with third-party or private providers
- Proven ability to align complex cross-functional organizations, close evidence gaps, and shape external market environments to ensure sustainable patient access
- Strong people leadership track record, including building, managing, and inspiring high-performing teams and driving innovative approaches to market access
- Senior leadership experience in global, regional, and/or major market roles, with deep understanding of global healthcare systems (e.g., US, EU, Japan, China) and the ability to adapt strategies to diverse market archetypes
- Strategic foresight, adaptability, and resilience, with the ability to navigate complex global challenges, influence at senior levels, and drive innovation to maximize asset value